Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Syra Health Corp. (SYRA) had Cost of Goods Sold of $6.33M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$7.98M |
|
$-3.76M |
|
|
Cost of Goods Sold |
$6.33M |
$1.65M |
|
$11.75M |
|
$-3.76M |
|
$0.01M |
|
$-3.76M |
|
$-3.76M |
|
$-3.76M |
|
$-3.76M |
|
$-3.76M |
|
$-3.76M |
|
$-3.76M |
|
$-3.70M |
|
7.55M |
|
7.55M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$3.35M |
|
$0.03M |
|
$0.33M |
|
$3.68M |
|
$0.61M |
|
-- |
|
$0.19M |
|
$0.80M |
|
$2.88M |
|
$2.88M |
|
$2.88M |
|
9.81M |
|
| Cash Flow Statement Financials | |
$-2.93M |
|
$-0.01M |
|
$2.06M |
|
$3.28M |
|
$2.40M |
|
$-0.88M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.46 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
20.71% |
|
-47.17% |
|
-47.17% |
|
-46.38% |
|
-47.10% |
|
-47.10% |
|
$-2.94M |
|
-- |
|
-- |
|
-- |
|
2.17 |
|
-- |
|
11.72 |
|
31.13 |
|
-130.59% |
|
-130.59% |
|
-102.17% |
|
-130.59% |
|
$0.29 |
|
$-0.39 |
|
$-0.39 |
|